| Product Name | MF | CAS | Details |
|---|
| 6-Methylheptanal | C8H16O | 63885-09-6 | Details |
| Drafloxacin Impurity 13 | C36H24Cl2F6N8O8 | 1093185-35-3 | Details |
| Delafloxacin Impurity 3 | C17H12ClF3N4O2 | 2097714-12-8 | Details |
| methyl4-((2S,4S)-4-ethoxypiperidin-2-yl)benzoate | C15H21NO3 | 1644667-61-7 | Details |
| 2,5-dimethyl-1,2,4-triazolo<1,5-a>-7(4H)-pyrimidone | C7H8N4O | 89852-99-3 | Details |
| 4-methylvaleraldehyde | C6H12O | 1119-16-0 | Details |
| 8-methoxy-3-methyl-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole fumarate | C18H22N2O5 | 2483829-59-8 | Details |
| 4-(aminomethyl)-2-bromobenzonitrile | C8H7BrN2 | 1177558-39-2 | Details |
| Drafloxacin Impurity 9 | Details |
| 2-PIPERIDIN-4-YL-1H-BENZOIMIDAZOLE | C12H15N3 | 38385-95-4 | Details |
| 5-HydroxyMethyl-N,N-diMethyltryptaMine | C13H18N2O | 334981-08-7 | Details |
| Vonoprazan | C17H16FN3O2S | 881681-00-1 | Details |
| Drafloxacin Impurity 17 | Details |
| 2-Fluoro-4-Mercapto-Aniline | C6H6FNS | 15178-48-0 | Details |
| 3,5-Difluoropyridine-2,6-diamine | C5H5F2N3 | 247069-27-8 | Details |
| 2-phenylpentanedioic acid | C11H12O4 | 2628-87-7 | Details |
| (S)-1-(tert-Butoxycarbonyl)-4,4-dimethylpyrrolidine-2-carboxylic acid | C12H21NO4 | 1001353-87-2 | Details |
| (1-Bromo-2,2,2-trifluoroethyl)benzene | C8H6BrF3 | 434-42-4 | Details |
| 2-BroMo-4-fluoro-5-Methoxybenzoic acid | C8H6BrFO3 | 1007455-21-1 | Details |
| 1,2,8-OCTANETRIOL | C8H18O3 | 382631-43-8 | Details |
| Drafloxacin Impurity 5 | C18H12ClF3N4O4 | 2097714-11-7 | Details |
| 4-(3-AMINO-PROPYL)-1H-IMIDAZOL-2-YLAMINE 2HCL | C6H14Cl2N4 | 80822-62-4 | Details |
| 5-Amino-2,6-dimethylpyrimidine | C6H9N3 | 35733-53-0 | Details |
| 2-mercaptopropanol | C3H8OS | 3001-64-7 | Details |
| 5,5-DIMETHYL-DIHYDRO-FURAN-2-ONE | C6H10O2 | 3123-97-5 | Details |
| 7-bromo-1-methyl-1,3-dihydro-2H-benzimidazol-2-one | C8H7BrN2O | 913297-44-6 | Details |
| ethyl 4,7-dihydro-2-methyl-7-oxo-[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxylate | C9H10N4O3 | 99179-11-0 | Details |
| Drafloxacin Impurity 6 | Details |
| ({N-[(9H-Fluoren-9-ylmethoxy)carbonyl]glycyl}amino)methyl acetate | C20H20N2O5 | 1599440-06-8 | Details |
| METHYLSULFONYLMETHANAMINE | C2H7NO2S | 385369-67-5 | Details |
| 5-methyl-4-hexenoic acid | C7H12O2 | 5636-65-7 | Details |
| 3-Pyridinecarboxylic acid, 4-amino-6-chloro-5-fluoro-, ethyl ester | C8H8ClFN2O2 | 2454397-74-9 | Details |
| 2-methyl-[1,2,4]triazolo[1,5-a]pyrimidine-5,7-diol | C6H6N4O2 | 1567029-19-9 | Details |
| (Methylsulfonyl)methanamine hydrochloride | C2H8ClNO2S | 1956319-73-5 | Details |
| DIETHYL 2,2-DIMETHYLGLUTARATE | C11H20O4 | 78092-07-6 | Details |
| N-methanesulfonylmethyl-phthalimide | Details |
| 2-Bromopyrimidine-4-carbonitrile | C5H2BrN3 | 1209459-16-4 | Details |
| 2-(5-Bromo-4-oxopentyl)-1H-isoindole-1,3(2H)-dione | C13H12BrNO3 | 41306-64-3 | Details |
| 1-(2-Ethoxy-ethyl)-2-piperidin-4-yl-1H-benzimidazole | C16H23N3O | 110963-63-8 | Details |
| GSK1349572 | C20H19F2N3O5 | 1051375-16-6 | Details |
| Delafloxacin Impurity 1 | C17H12ClF3N4O3 | 2097714-10-6 | Details |
| 4-FLUORO-3-NITROPHENYL)ACETONITRILE | C8H5FN2O2 | 157662-77-6 | Details |
| Drafloxacin Impurity 2 | Details |
| SKQ1 Bromide | C36H42BrO2P | 934826-68-3 | Details |
| 1-Acetyl-3-indolinone | C10H9NO2 | 16800-68-3 | Details |
| 2-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine | C6H7N5 | 1435464-72-4 | Details |
| aminomethyl acetate | C3H7NO2 | 97423-53-5 | Details |
| 4-MERCAPTO-4-METHYLVALERIC ACID | C6H12O2S | 140231-31-8 | Details |
| Ethyl 3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxylate | C8H10F2N2O2 | 141573-95-7 | Details |
| 4-AMino-7-broMoiMidazo[2,1-f][1,2,4]triazine | C5H4BrN5 | 1235374-44-3 | Details |
| Drafloxacin Impurity 4 | Details |
| Drafloxacin Impurity 14 | C18H14ClF3N4O5 | 208165-59-7 | Details |
| Cyclopropanepropanoic acid, 1-carboxy- | C7H10O4 | 33229-05-9 | Details |
| Dimercaptosuccinic acid | C4H6O4S2 | 2418-14-6 | Details |
| 1,2,3,4,5,6-Hexahydro-3-methylazepino[4,5-b]indole | C13H16N2 | 7546-66-9 | Details |
| 2-chloro-3-fluoropyridin-4-aMine | C5H4ClFN2 | 1227577-03-8 | Details |
| 8-Bromo-7-methoxy-1,2,3,4-tetrahydro-naphthalen-1-one | C11H11BrO2 | 61362-78-5 | Details |
| 4-methyl-pent-3-enoic acid | C6H10O2 | 504-85-8 | Details |
| Drafloxacin Impurity 16 | Details |
| Drafloxacin Impurity 10 | C29H17F6N3O6 | 906088-97-9 | Details |
| Product Total： Product Page： | ||||
| 1 | ||||